News & Events

2021, Press Releases, Scientific

Philochem, InterX and Scripps Research announce a Research Collaboration in the Field of DNA-Encoded Chemistry and Tumor Targeting

Aug 23, 2021

Philochem, a wholly owned subsidiary of Philogen S.p.A., InterX, Inc and Scripps Research announce a research collaboration to develop a best-in-class tumor targeting agent for metastatic prostate cancer.

Last News & Events

Feb 2021 1

Philogen announces its intention to float on the Mercato Telematico Azionario organised and managed by Borsa Italiana S.P.A

Jan 2021 13

Philogen announces the completion of a second interim analysis of its phase III clinical program with NidlegyTM for the treatment of melanoma

« Previous
1
…
107
108
109
110
111
…
125
Next »